Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.43B |
| 2 |
Accenture
ACN
|
+$355M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$278M |
| 4 |
JPMorgan Chase
JPM
|
+$250M |
| 5 |
Pfizer
PFE
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$409M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$380M |
| 3 |
GE Aerospace
GE
|
+$377M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$249M |
| 5 |
CELG
Celgene Corp
CELG
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.16% |
| 2 | Financials | 9.51% |
| 3 | Industrials | 8.89% |
| 4 | Healthcare | 8.81% |
| 5 | Consumer Discretionary | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Elevance Health
ELV
$82.1B
| $261M | 0.08% |
1,160,085
+314,451
| +37% | +$67M |
|
277
Ameren
AEE
$31B
| $261M | 0.08% |
4,421,901
-56,867
| -1% | -$3.49M |
|
278
Kohl's
KSS
$2.1B
| $261M | 0.08% |
4,804,605
+123,281
| +3% | +$5.67M |
|
279
Arch Capital
ACGL
$36.3B
| $258M | 0.07% |
8,543,148
+1,309,347
| +18% | +$41.9M |
|
|
KSU
280
DELISTED
Kansas City Southern
KSU
| $258M | 0.07% |
2,454,985
+50,253
| +2% | +$5.36M |
|
281
Aptiv
APTV
$12.2B
| $258M | 0.07% |
3,036,786
+1,223,778
| +67% | +$117M |
|
282
Occidental Petroleum
OXY
$54.6B
| $257M | 0.07% |
3,488,268
-132,532
| -4% | -$9M |
|
283
McKesson
MCK
$99.5B
| $256M | 0.07% |
1,641,353
-119,513
| -7% | -$17.7M |
|
284
Vodafone
VOD
$36.4B
| $256M | 0.07% |
8,016,824
+143,404
| +2% | +$4.3M |
|
285
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $254M | 0.07% |
2,965,803
-182,483
| -6% | -$15.3M |
|
286
GSK
GSK
$104B
| $254M | 0.07% |
5,724,976
-4,274,730
| -43% | -$197M |
|
287
Wells Fargo
WFC
$264B
| $253M | 0.07% |
4,162,371
-162,818
| -4% | -$9.2M |
|
|
AET
288
DELISTED
Aetna Inc
AET
| $251M | 0.07% |
1,391,889
+26,293
| +2% | +$4.52M |
|
|
SCHW
289
Charles Schwab
SCHW
$181B
| $250M | 0.07% |
4,858,417
+64,802
| +1% | +$3.04M |
|
|
AGN
290
DELISTED
Allergan plc
AGN
| $249M | 0.07% |
1,523,578
-222,212
| -13% | -$39.9M |
|
291
Zimmer Biomet
ZBH
$17.8B
| $247M | 0.07% |
2,105,706
+1,046,567
| +99% | +$118M |
|
292
Willis Towers Watson
WTW
$28.6B
| $246M | 0.07% |
1,635,349
+179,146
| +12% | +$28.3M |
|
293
Travelers Companies
TRV
$81.4B
| $245M | 0.07% |
1,807,214
+239,325
| +15% | +$31.6M |
|
|
APC
294
DELISTED
Anadarko Petroleum
APC
| $244M | 0.07% |
4,542,942
-189,918
| -4% | -$9.34M |
|
|
PACW
295
DELISTED
PacWest Bancorp
PACW
| $243M | 0.07% |
4,815,057
+468,841
| +11% | +$22.4M |
|
|
VMW
296
DELISTED
VMware, Inc
VMW
| $242M | 0.07% |
1,929,641
+137,274
| +8% | +$16.5M |
|
|
ULTI
297
DELISTED
Ultimate Software Group Inc
ULTI
| $239M | 0.07% |
1,095,341
-110,710
| -9% | -$22.5M |
|
298
MarketAxess Holdings
MKTX
$4.19B
| $238M | 0.07% |
1,181,609
-50,925
| -4% | -$9.61M |
|
299
AB InBev
BUD
$156B
| $238M | 0.07% |
2,135,448
-416
| -0% | -$48.9K |
|
300
British American Tobacco
BTI
$131B
| $237M | 0.07% |
3,542,767
+680,783
| +24% | +$44.4M |
|
Similar funds
Wells Fargo's Q4 2017 Portfolio in Review
As of Q4 2017, Wells Fargo held 6,830 positions worth $346B, up 7.2% from $323B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Wells Fargo's Q4 2017 filing shows 328 new, 3,316 increased, 2,212 reduced and 301 closed positions. Its largest new stake was Switch, Inc. Class A Common Stock: 4,215,682 shares worth $76.7M. The largest sale was VanEck Junior Gold Miners ETF, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- Wells Fargo's largest Q4 2017 buy was Switch, Inc. Class A Common Stock: 4,215,682 shares worth $76.7M.
- Wells Fargo added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $1.43B increase.
- Wells Fargo's biggest Q4 2017 reduction was VanEck Junior Gold Miners ETF, cutting an estimated $409M.
- Wells Fargo fully exited CR Bard Inc. in Q4 2017, selling an estimated $249M.
- Wells Fargo's ten largest holdings make up 14% of its $346B portfolio in Q4 2017.
- Wells Fargo opened 328 new positions and closed 301 in Q4 2017.
- Wells Fargo's portfolio value rose 7.2% quarter-over-quarter to $346B.
Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.